Platelet quality after 15‐day storage of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium

It has been reported previously that platelet concentrates (PCs) prepared from buffy coat pools diluted in a simple, glucose‐free medium (BC‐PCs) are effective in thrombocytopenic patients after 4 to 12 days of storage. Such preparations produce platelet increments similar to those of traditional PCs prepared from platelet‐rich plasma (PRP‐PCs) stored for 1 to 3 days. The purpose of this study was to obtain a series of in vitro measurements during storage to allow a more detailed characterization of BC‐PCs and a more detailed comparison of BC‐PCs with PRP‐PCs. At the beginning of storage, the level of (alpha granule membrane protein‐140 (GMP‐140), a marker of platelet activation, was significantly higher on PRP‐PC platelets, and BC‐PCs were superior in measurements reflecting platelet function, such as osmotic reversal, ATP release, and aggregation with collagen. Compared to PRP‐PCs, BC‐PCs were superior in the percentage of discs, total ATP, and glycoprotein lb expression by Day 7. This superiority became more striking on Day 11. Overall, 15‐day‐old BC‐PCs compared favorably to 7‐day old PRP‐PCs: BC‐PCs were superior in ATP release and aggregation with collagen, but they were not significantly different for all other measurements reflecting platelet quality and function. Thus, the quality of platelets in BC‐PCs was superior on Day 1, and this superiority progressed as storage continued. In addition, the metabolism of BC‐PCs was favorable. During 15 days of storage, pH and bicarbonate concentration did not change significantly In BC‐PCs; moreover, oxygen consumption was higher and glucose utilization and lactate accumulation were markedly slower than in PRP‐PCs. The results of additional experiments performed with pooled PRP‐PCs diluted In the glucose‐free medium and stored In the same fashion as BCPCs were Intermediate between those of experiments with BCPCs and PRP‐PCs, which suggests that the superior quality of BC‐PCs Is due In part to the buffy coat method of pre aration and In part to one or more components of the storage method. This approach to platelet procurement and storage has the disadvantage of a lower platelet yield. However, it can be concluded that it produces platelets of higher quality, contaminated with fewer white cells and less plasma and with better potential for storage than is possible with PRP‐PCs.

[1]  D. Riccardi,et al.  Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium , 1989, Transfusion.

[2]  F. Oosterhof,et al.  A Simple Immunofluorescence Test for the Detection of Platelet Antibodies , 1978, British journal of haematology.

[3]  D. Roos,et al.  Platelet activation during preparation of platelet concentrates: a comparison of the platelet‐rich plasma and the buffy coat methods , 1990, Transfusion.

[4]  L. Corash,et al.  PHOTOCHEMICAL DECONTAMINATION OF BLOOD COMPONENTS CONTAINING HEPATITIS B AND NON-A, NON-B VIRUS , 1988, The Lancet.

[5]  S. Murphy,et al.  Stored human platelets retain full aggregation potential in response to pairs of aggregating agents. , 1982, Blood.

[6]  David T. Miller,et al.  Metabolic Status of Platelet Concentrates during Extended Storage: Improvement with Pharmacological Inhibitors and Reduced Surface‐to‐Volume Ratio , 1989, Vox sanguinis.

[7]  H. Kiyokawa,et al.  Prevention of acquired defects in platelet function during blood processing , 1988, Transfusion.

[8]  B. Furie,et al.  A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. , 1984, The Journal of biological chemistry.

[9]  H. Reesink,et al.  Comparison of a Conventional Quadruple‐Bag System with a ‘Top‐and‐Bottom’ System for Blood Processing , 1990, Vox sanguinis.

[10]  S. Murphy,et al.  Comparative measurements of platelet size by Coulter Counter, microscopy of blood smears, and light-transmission studies. Relationship between platelet size and shape. , 1981, The Journal of laboratory and clinical medicine.

[11]  E. Kinney Primer of Biostatistics , 1987 .

[12]  C. Högman,et al.  Platelet Concentrates in an Additive Solution Prepared from Pooled Buffy Coats , 1993, Vox sanguinis.

[13]  P. Rebulla,et al.  Comparison of Platelet Activation and Membrane Glycoprotein Ib and IIb‐IIIa Expression after Filtration through Three Different Leukocyte Removal Filters , 1990, Vox sanguinis.

[14]  D. Roos,et al.  Preparation of leukocyte-poor platelet concentrates from buffy coats. III. Effect of leukocyte contamination on storage conditions. , 1988, Vox sanguinis.

[15]  C. Högman,et al.  Platelet Concentrates in an Additive Solution Prepared from Pooled Buffy Coats. , 1990, Vox sanguinis.

[16]  H. Reesink,et al.  Platelet Concentrates Stored in Plasma for 72 Hours at 22°C Prepared from Buffycoats of Citrate‐Phosphate‐Dextrose Blood Collected in a Quadruple‐Bag Saline‐Adenine‐Glucose‐Mannitol System , 1985, Vox sanguinis.

[17]  S. Murphy,et al.  Platelet metabolism during storage of platelet concentrates at 22 degrees C. , 1984, Blood.

[18]  R. Aster,et al.  Importance of White Blood Cells in Platelet Storage 1 , 1984, Vox sanguinis.

[19]  Laurence Corash,et al.  Use of 8-methoxypsoralen and long-wavelength ultraviolet radiation for decontamination of platelet concentrates , 1989, Photonics West - Lasers and Applications in Science and Engineering.

[20]  R. Kahn,et al.  Improved storage of platelets for transfusion in a new container. , 1982, Blood.

[21]  H. Kiyokawa,et al.  Preparation of white‐cell‐poor blood components using a quadruple bag system , 1988, Transfusion.

[22]  S. Holme,et al.  Platelet Storage Lesion in Second‐Generation Containers: Correlation with Platelet ATP Levels , 1987, Vox sanguinis.

[23]  G. Moroff,et al.  Factors Influencing Changes in pH during Storage of Platelet Concentrates at 20–24°C 1, 2 , 1982 .

[24]  G. Rock,et al.  Storage of human platelet concentrates in an artificial medium without dextrose , 1988, Transfusion.

[25]  D. Wagner,et al.  PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes , 1989, Cell.

[26]  S. Holme,et al.  Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution , 1987, British journal of haematology.